About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Media coverage
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
PregInPoxVac maternal protocol: a phase 3 trial evaluating maternal immunogenicity and safety of the MVA-BN vaccine in the Democratic Republic of the Congo
Mpox vaccine trial in pregnant and post-partum individuals: PregInPoxVac maternal protocol now published
New D3 (PENTA-21) findings add reassurance about simplified HIV treatment for children
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate
Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study
High Early Post-Discharge Mortality and Readmission in Children Living with HIV in Sub-Saharan Africa: 30-Day Outcomes from the SUPPORT Project
High prevalence of ESBL-producing bacteria isolated from rectal swabs of children living with HIV at the time of hospital discharge
“Will she get better or worse at home?” A qualitative study on caregivers’ and healthcare providers’ perspectives on post-discharge mortality risk in paediatric HIV care in Mozambique
Retrospective evaluation of school-related measures on pre-vaccination transmission dynamics of SARS-CoV-2
Cross-network, multicentre cohort study assessing real-world pregnancy and birth outcomes following prenatal dolutegravir exposure in Europe
Every-8-weeks injectable cabotegravir and rilpivirine is superior to daily oral tenofovir disoproxil fumarate/ lamivudine/ dolutegravir in adolescents living with HIV in sub-Saharan Africa: LATA 96-week results
Sustained undetectable intact reservoir in early treated infants in Africa
Sustaining advanced HIV disease care: Lessons from program integration and country experiences
Knowledge, Training, and Implementation Gaps in Delivery of the STOP AIDS Package for Pediatric Advanced HIV Disease: A Multi-Country Assessment
Demographic, laboratory and clinical characteristics and outcomes of seriously ill hospitalized Mozambican children with advanced HIV disease
Uncovering the gaps: a mixed methods exploration of barriers to STOP-AIDS implementation
Addressing gaps in provider-initiated testing and counseling and early infant diagnosis to optimize inpatient pediatric advanced HIV disease care in Mozambican hospitals
Implementation of the advanced HIV disease care package for hospitalized children: baseline results from a Quality Improvement initiative in Mozambique